Frontlight ResearchEarly access
Trial site
Palmetto Clinical Research
- 7running trials
- 13closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)5 trials
- Type 2 diabetes5 trials
- Alzheimer disease4 trials
- Coronary artery disease2 trials
- Multiple sclerosis2 trials
- Obesity2 trials
- Stroke2 trials
- Endometriosis1 trial
- Irritable bowel syndrome1 trial
- Liver cirrhosis1 trial
- Mild cognitive impairment1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 314 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S5 trials
- Boehringer Ingelheim4 trials
- Novartis Pharmaceuticals3 trials
- Cassava Sciences, Inc.2 trials
- Amgen1 trial
- and 5 more
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)3 recruiting
- Liver cirrhosis1 recruiting
- Obesity1 recruiting
Closed trials
Terminated
Completed
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026